Completed
A First-in-human, Proof of Concept Study of CPK850 in Patients With RLBP1 Retinitis Pigmentosa
NCT03374657
- Conditions
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Eye Diseases, Hereditary, +5 more
- Locations
-
- Novartis Investigative Site Stockholm, Sweden